International Journal of Hematology and Oncology
2017 , Vol 27 , Num 1
Ozden HATIRNAZNG, Sinem FIRTINA, Yucel ERBILGIN, Ugur OZBEK, Muge SAYITOGLU
Aberrant Hypermethylation of APC Tumor Supressor Gene in Acute Leukemia Patients. UHOD , 2017 , 27 , 1-7
Erna ISLAMAGIC, Sabira KURTOVIC, Mirza KOZARIC, Emina S. HADZIMESIC, Azra HASIC, Lejla MEHINOVIC, Amina KURTOVIC-KOZARIC The Three Year Follow-up of CML Patients Treated with First-line Generic and First-line Branded Imatinib in Bosnia and Herzegovina. UHOD , 2017 , 27 , 8-12
H. Saygin DEMIREL, Pelin TASDEMIR, Sumeyra CETINKAYA, Ilknur CINAR, Tevfik KUCUKKARTALLAR, Gul DURSUN Colorectal Cancer Risk in Relation to Hypoxia Inducible Factor-1α (Hif-1 α) and Von Hippel-Lindau (Vhl) Gene Polymorphisms. UHOD , 2017 , 27 , 13-20
Nazan ERAS, Anil TOMBAK, Naci TIFTIK, Serap YALIN, Mehmet BERKOZ, Seval KUL, Etem AKBAS Association Between PON1 L55M Polymorphism and PON1 Enzyme Activity in Patients with Leukemia. UHOD , 2017 , 27 , 21-28
Mustafa KANDAZ, O. Cem GULER, Adnan YONEY The Effect of Chemoradiotherapy at Gastric Cancer on Pancreatic Enzymes and Pancreas Volume. UHOD , 2017 , 27 , 29-36
Fawaz D. ALSHAMMARI Molecular Screening for PTEN Gene Mutation Among Cigarette Smokers and Assessment of Knowledge of the Link Between Tobacco Use, and Cancer Among Saudi Population. UHOD , 2017 , 27 , 37-42
Gül PINAR, Tevfik PINAR, Ayşe DURUKAN, Ali AYHAN Prognostic Factors Affecting Survival in Patients with Ovarian Cancer: A 5-Year Experience in an University Hospital. UHOD , 2017 , 27 , 43-52
A. Ali BESEN, Fatih KOSE, Ahmet T. SUMBUL, Nuriye OZDEMIR, Ozgur OZYILKAN, Nurullah ZENGIN, Huseyin ABALI Flare Phenomenon in Advanced Colorectal Cancer: Cessation of Bevacizumab after Predefined Cycles of Therapy may not Affect Outcome. UHOD , 2017 , 27 , 53-59
Seher N. KAZAZ, Ilhan OZTOP Treatment After Crizotinib Resistance in ALK+ Non-Small-Cell Lung Cancer. UHOD , 2017 , 27 , 60-68
Erna ISLAMAGIC, Sabira KURTOVIC, Mirza KOZARIC, Emina S. HADZIMESIC, Azra HASIC, Lejla MEHINOVIC, Amina KURTOVIC-KOZARIC The Three Year Follow-up of CML Patients Treated with First-line Generic and First-line Branded Imatinib in Bosnia and Herzegovina. UHOD , 2017 , 27 , 8-12
H. Saygin DEMIREL, Pelin TASDEMIR, Sumeyra CETINKAYA, Ilknur CINAR, Tevfik KUCUKKARTALLAR, Gul DURSUN Colorectal Cancer Risk in Relation to Hypoxia Inducible Factor-1α (Hif-1 α) and Von Hippel-Lindau (Vhl) Gene Polymorphisms. UHOD , 2017 , 27 , 13-20
Nazan ERAS, Anil TOMBAK, Naci TIFTIK, Serap YALIN, Mehmet BERKOZ, Seval KUL, Etem AKBAS Association Between PON1 L55M Polymorphism and PON1 Enzyme Activity in Patients with Leukemia. UHOD , 2017 , 27 , 21-28
Mustafa KANDAZ, O. Cem GULER, Adnan YONEY The Effect of Chemoradiotherapy at Gastric Cancer on Pancreatic Enzymes and Pancreas Volume. UHOD , 2017 , 27 , 29-36
Fawaz D. ALSHAMMARI Molecular Screening for PTEN Gene Mutation Among Cigarette Smokers and Assessment of Knowledge of the Link Between Tobacco Use, and Cancer Among Saudi Population. UHOD , 2017 , 27 , 37-42
Gül PINAR, Tevfik PINAR, Ayşe DURUKAN, Ali AYHAN Prognostic Factors Affecting Survival in Patients with Ovarian Cancer: A 5-Year Experience in an University Hospital. UHOD , 2017 , 27 , 43-52
A. Ali BESEN, Fatih KOSE, Ahmet T. SUMBUL, Nuriye OZDEMIR, Ozgur OZYILKAN, Nurullah ZENGIN, Huseyin ABALI Flare Phenomenon in Advanced Colorectal Cancer: Cessation of Bevacizumab after Predefined Cycles of Therapy may not Affect Outcome. UHOD , 2017 , 27 , 53-59
Seher N. KAZAZ, Ilhan OZTOP Treatment After Crizotinib Resistance in ALK+ Non-Small-Cell Lung Cancer. UHOD , 2017 , 27 , 60-68